Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Anti-inflammatory effect of yoghurt in an experimental inflammatory bowel disease in mouse.

Gobbato N, Rachid M, Perdigón G.

J Dairy Res. 2008 Nov;75(4):497-504. doi: 10.1017/S0022029908003579.

PMID:
19032800
2.

Role of yoghurt in the prevention of colon cancer.

Perdigón G, de Moreno de LeBlanc A, Valdez J, Rachid M.

Eur J Clin Nutr. 2002 Aug;56 Suppl 3:S65-8. Review.

3.

Yoghurt consumption regulates the immune cells implicated in acute intestinal inflammation and prevents the recurrence of the inflammatory process in a mouse model.

Chaves S, Perdigon G, de Moreno de LeBlanc A.

J Food Prot. 2011 May;74(5):801-11. doi: 10.4315/0362-028X.JFP-10-375.

PMID:
21549052
4.

The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.

Aharoni R, Sonego H, Brenner O, Eilam R, Arnon R.

Immunol Lett. 2007 Oct 15;112(2):110-9. Epub 2007 Aug 8.

PMID:
17719654
5.

The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease.

Mencarelli A, Renga B, Palladino G, Distrutti E, Fiorucci S.

Biochem Pharmacol. 2009 Nov 1;78(9):1214-23. doi: 10.1016/j.bcp.2009.06.026. Epub 2009 Jun 23.

PMID:
19555671
6.

Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.

Drouault-Holowacz S, Foligné B, Dennin V, Goudercourt D, Terpend K, Burckel A, Pot B.

Clin Nutr. 2006 Dec;25(6):994-1003. Epub 2006 May 15.

PMID:
16698150
7.

Antitumour activity of yogurt: study of possible immune mechanisms.

Perdigón G, Valdez JC, Rachid M.

J Dairy Res. 1998 Feb;65(1):129-38.

PMID:
9513059
8.

Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease.

Kim YS, Son M, Ko JI, Cho H, Yoo M, Kim WB, Song IS, Kim CY.

Arch Pharm Res. 1999 Aug;22(4):354-60.

PMID:
10489873
9.

Imaging of intestinal lymphocyte homing by means of pinhole SPECT in a TNBS colitis mouse model.

Bennink RJ, van Montfrans C, de Jonge WJ, de Bruin K, van Deventer SJ, te Velde AA.

Nucl Med Biol. 2004 Jan;31(1):93-101.

PMID:
14741574
10.

Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease.

Laverny G, Penna G, Vetrano S, Correale C, Nebuloni M, Danese S, Adorini L.

Immunol Lett. 2010 Jun 15;131(1):49-58. doi: 10.1016/j.imlet.2010.03.006. Epub 2010 Mar 27.

PMID:
20350569
11.

The effects of dietary curcumin and rutin on colonic inflammation and gene expression in multidrug resistance gene-deficient (mdr1a-/-) mice, a model of inflammatory bowel diseases.

Nones K, Dommels YE, Martell S, Butts C, McNabb WC, Park ZA, Zhu S, Hedderley D, Barnett MP, Roy NC.

Br J Nutr. 2009 Jan;101(2):169-81. doi: 10.1017/S0007114508009847. Epub 2008 Sep 2.

PMID:
18761777
12.

Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.

Shteingart S, Rapoport M, Grodzovski I, Sabag O, Lichtenstein M, Eavri R, Lorberboum-Galski H.

Gut. 2009 Jun;58(6):790-8. doi: 10.1136/gut.2008.153981. Epub 2008 Oct 31.

PMID:
18978179
13.

Suppression of colon inflammation by CD80 blockade: evaluation in two murine models of inflammatory bowel disease.

Eri R, Kodumudi KN, Summerlin DJ, Srinivasan M.

Inflamm Bowel Dis. 2008 Apr;14(4):458-70. doi: 10.1002/ibd.20344.

PMID:
18186109
14.

Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.

Aharoni R, Kayhan B, Brenner O, Domev H, Labunskay G, Arnon R.

J Pharmacol Exp Ther. 2006 Jul;318(1):68-78. Epub 2006 Apr 19.

15.

Glutathione peroxidase 2 and aquaporin 8 as new markers for colonic inflammation in experimental colitis and inflammatory bowel diseases: an important role for H2O2?

Te Velde AA, Pronk I, de Kort F, Stokkers PC.

Eur J Gastroenterol Hepatol. 2008 Jun;20(6):555-60. doi: 10.1097/MEG.0b013e3282f45751.

PMID:
18467915
16.

Immunomodulatory effects of ciprofloxacin in TNBS-induced colitis in mice.

Lahat G, Halperin D, Barazovsky E, Shalit I, Rabau M, Klausner J, Fabian I.

Inflamm Bowel Dis. 2007 May;13(5):557-65.

PMID:
17253612
17.

MIP-3alpha neutralizing monoclonal antibody protects against TNBS-induced colonic injury and inflammation in mice.

Katchar K, Kelly CP, Keates S, O'brien MJ, Keates AC.

Am J Physiol Gastrointest Liver Physiol. 2007 May;292(5):G1263-71. Epub 2007 Feb 1.

18.

Intestinal immunomodulation. Role of regulative peptides and promising pharmacological activities.

Motilva V, Talero E, Calvo JR, Villegas I, Alarcón-de-la-Lastra C, Sánchez-Fidalgo S.

Curr Pharm Des. 2008;14(1):71-95. Review.

PMID:
18220820
19.

Role of animal models for the pathogenesis and treatment of inflammatory bowel disease.

Dieleman LA, Peña AS, Meuwissen SG, van Rees EP.

Scand J Gastroenterol Suppl. 1997;223:99-104. Review.

PMID:
9200314
20.

Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.

González MA, Gonzalez-Rey E, Rico L, Büscher D, Delgado M.

Gastroenterology. 2009 Mar;136(3):978-89. doi: 10.1053/j.gastro.2008.11.041. Epub 2008 Nov 27.

PMID:
19135996
Items per page

Supplemental Content

Write to the Help Desk